Dr. Brian Strom, MD

NPI: 1922035831
Total Payments
$80,058
2021 Payments
$11,400
Companies
11
Transactions
64

Payment Breakdown by Category

Consulting$69,578 (86.9%)
Travel$5,371 (6.7%)
Other$3,000 (3.7%)
Research$1,376 (1.7%)
Food & Beverage$734.12 (0.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $69,578 17 86.9%
Travel and Lodging $5,371 21 6.7%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,000 1 3.7%
Unspecified $1,376 1 1.7%
Food and Beverage $734.12 24 0.9%

Payments by Type

General
$78,683
63 transactions
Research
$1,376
1 transactions

Top Paying Companies

Company Total Records Latest Year
Janssen Research & Development, LLC $29,552 22 $0 (2019)
BioDelivery Sciences International, Inc. $11,044 7 $0 (2018)
AMAG Pharmaceuticals, Inc. $8,515 9 $0 (2018)
Lundbeck LLC $7,500 4 $0 (2021)
Bayer HealthCare Pharmaceuticals Inc. $7,076 6 $0 (2017)
Allergan, Inc. $6,900 3 $0 (2021)
Celgene Corporation $3,000 1 $0 (2018)
Mallinckrodt LLC $2,380 1 $0 (2018)
Teva Pharmaceuticals USA, Inc. $1,376 1 $0 (2018)
Par Pharmaceutical, Inc. $1,358 5 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2021 $11,400 4 Lundbeck LLC ($6,600)
2020 $2,100 2 Allergan, Inc. ($2,100)
2019 $11,835 7 Janssen Research & Development, LLC ($10,935)
2018 $29,031 29 BioDelivery Sciences International, Inc. ($11,044)
2017 $25,693 22 Janssen Research & Development, LLC ($18,617)

All Payment Transactions

64 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
09/09/2021 Lundbeck LLC NORTHERA (Drug) Consulting Fee Cash or cash equivalent $2,100.00 General
Category: NEUROLOGY
05/04/2021 Lundbeck LLC NORTHERA (Drug) Consulting Fee Cash or cash equivalent $3,000.00 General
Category: NEUROLOGY
05/04/2021 Lundbeck LLC NORTHERA (Drug) Consulting Fee Cash or cash equivalent $1,500.00 General
Category: NEUROLOGY
04/08/2021 Allergan, Inc. Consulting Fee Cash or cash equivalent $4,800.00 General
05/30/2020 Allergan, Inc. NATRELLE (Device) Consulting Fee Cash or cash equivalent $900.00 General
Category: PLASTICS
05/20/2020 Allergan, Inc. Consulting Fee Cash or cash equivalent $1,200.00 General
11/22/2019 Lundbeck LLC NORTHERA (Drug) Consulting Fee Cash or cash equivalent $900.00 General
Category: NEUROLOGY
02/28/2019 Janssen Research & Development, LLC Consulting Fee Cash or cash equivalent $10,197.82 General
02/28/2019 Janssen Research & Development, LLC Travel and Lodging Cash or cash equivalent $40.96 General
02/09/2019 Janssen Research & Development, LLC Travel and Lodging In-kind items and services $581.52 General
02/09/2019 Janssen Research & Development, LLC Food and Beverage In-kind items and services $50.00 General
02/09/2019 Janssen Research & Development, LLC Food and Beverage In-kind items and services $35.00 General
02/09/2019 Janssen Research & Development, LLC Food and Beverage In-kind items and services $30.00 General
10/31/2018 AMAG Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $7,500.00 General
10/31/2018 AMAG Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $63.24 General
10/31/2018 AMAG Pharmaceuticals, Inc. Food and Beverage Cash or cash equivalent $15.00 General
10/31/2018 AMAG Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $10.00 General
09/22/2018 Mallinckrodt LLC Consulting Fee Cash or cash equivalent $2,379.92 General
09/22/2018 Teva Pharmaceuticals USA, Inc. Fentora (Drug) Cash or cash equivalent $1,375.51 Research
Study: Transmucosal Immediate Release Fentanyl (TIRF) Risk Evaluation and Mitigation Strategy (REMS) program • Category: Central Nervous System
09/22/2018 Par Pharmaceutical, Inc. Consulting Fee Cash or cash equivalent $1,200.00 General
09/22/2018 Sentynl Therapeutics, Inc. Abstral (Drug) Consulting Fee Cash or cash equivalent $1,200.00 General
Category: Pharmacology/Toxicology
09/22/2018 Par Pharmaceutical, Inc. Travel and Lodging Cash or cash equivalent $14.63 General
09/22/2018 Sentynl Therapeutics, Inc. Abstral (Drug) Travel and Lodging Cash or cash equivalent $14.63 General
Category: Pharmacology/Toxicology
09/22/2018 Par Pharmaceutical, Inc. Food and Beverage Cash or cash equivalent $4.33 General
09/22/2018 Par Pharmaceutical, Inc. Travel and Lodging Cash or cash equivalent $3.00 General

Research Studies & Clinical Trials

Study Name Company Amount Records
Transmucosal Immediate Release Fentanyl (TIRF) Risk Evaluation and Mitigation Strategy (REMS) program Teva Pharmaceuticals USA, Inc. $1,376 1

About Dr. Brian Strom, MD

Dr. Brian Strom, MD is a Internal Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922035831.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Strom, MD has received a total of $80,058 in payments from pharmaceutical and medical device companies, with $11,400 received in 2021. These payments were reported across 64 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($69,578).

Practice Information

  • Specialty Internal Medicine
  • Location Philadelphia, PA
  • Active Since 06/27/2006
  • Last Updated 09/17/2015
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1922035831

Products in Payments

  • BUNAVAIL 2.1 mg 30-count box (Drug) $11,044
  • NORTHERA (Drug) $7,500
  • Gadavist (Drug) $7,076
  • Fentora (Drug) $1,376
  • Abstral (Drug) $1,358
  • NATRELLE (Device) $900.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Philadelphia